(15 March 2022) Amgen Korea (GM: Sang Noh) signed Memorandum of Understanding (MOU) for the Blue Wish Campaign with Make-A-Wish Korea (President: Sang-Il Park) on 10 March to fulfil wishes of children in Korea with critical illnesses.
Amgen Korea’s Blue Wish Campaign is a part of Amgen’s efforts to bring the corporate mission of “To Serve Patients” to life by providing emotional support for children with critical illnesses, while being socially responsible in the Korean society it serves. Make-A-Wish Korea, Amgen Korea’s partner for the Blue Wish Campaign, is the Korea office of the global Make-A-Wish Foundation, which has been making wishes a reality for over 500,000 children with critical illnesses around the world.
Amgen Korea employees who participate in the Blue Wish Campaign will follow the Wish Journey from wish discovery to wish granting for children with critical illnesses. They will be referred to children with whom they get to build relationships over 2 to 3 months via various channels to discover their wish and design a wish plan to make it possible. Wish-granting activities planned will be implemented on the Wish Day, with the objective of keeping children inspired and hopeful for treatment of their illnesses through positive experience and engagement.
Under the MOU, Amgen Korea will be working with and help Make-A-Wish Korea for the Blue Wish Campaign for the next 3 years (2022 to 2024).
Sang Noh, GM, Amgen Korea, said: “While innovative medicines make patients to survive, hope makes patients to live. I believe Amgen Korea’s Blue Wish Campaign can be an opportunity to inspire children with critical illnesses to stay hopeful and employees to have first-have experience of what overcoming a disease means to patients and the community. This campaign for children with critical illnesses is also one of our own ways of bringing Amgen’s corporate mission of ‘To Serve Patients’ to reality.”
“Amgen is driven by our ESG (Environmental, Social, and Governance) aspirations to help make the world a better place with our social influences of corporate activities. Amgen Korea will continue to work hard for development and supply of transformative therapies with unwavering commitment to social responsibilities for the members of our community who are fighting illnesses, as well shown in the Blue Wish Campaign,” he added.
Sang-Il Park, President, Make-A-Wish Korea, said: “Amgen Korea and Make-A-Wish Korea share the same goal of bringing hope for patients, which makes the MOU for the Blue Wish Campaign even more meaningful. The MOU marks an important reminder for Make-A-Wish Korea to help children with critical conditions stay strong to fight their illnesses through wish-granting experience with Amgen Korea.”
Amgen, one of the leading biotechnology companies, is working towards mid- and long-term business strategies which incorporate ESG commitment that not only supports but contributes to the achievement of the United Nations Sustainable Development Goals (UN-SDGs). Amgen’s ESG strategies are centered around the 7 high priorities: Business Ethics; Ethical Research; Access to Medicine; Diversity, Inclusion and Belonging; Environmental Sustainability; Responsible Sourcing; and Community Investment.
Guided by Amgen’s ESG commitment on a global level, Amgen Korea has joined the corporate-wide effort to be a socially responsible member in the Korean society. With a special focus on social values, Amgen Korea has been implementing the Corporate Responsibility 2025 Plan to promote diversity, inclusion and a stronger sense of belonging as well as to invest more in the local community.
An ESG program for social values encouraging employees to participate in wish-granting journey for children with critical diseases, Amgen Korea’s Blue Wish Campaign promotes a sense of belonging (Diversity, Inclusion and Belonging) while supporting children with critical illnesses, contributes to growth of the future generations of the Korean society (Community Investment).
Additionally, at the heart of the Corporate Responsibility 2025 Plan, Amgen Korea supports programs to discover and encourage remarkable life scientists in different life cycle stages as well as contribute to the local community, ranging from the Golden House Campaign for better living condition for the less privileged in the community to the Grow up, Bio up Campaign for life science education of children and adolescents, and Amgen-KAST Biotechnology Awards for promising young researchers in life science.